Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2033
  • 2034
  • 2035
  • …
  • ›
  • »

2026-04-20

Fox Corporation Executives to Discuss Third Quarter Fiscal 2026 Financial Results Via Webcast

2026-04-20

Planisware - Statement of own shares dealings - April 13 to 15, 2026

2026-04-20

GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)

2026-04-20

Multitude Group announces leadership changes in Wholesale Banking

2026-04-20

Paratus Energy: Notice of 2026 Annual General Meeting

2026-04-20

NATIONAL GEOGRAPHIC-LINDBLAD EXPEDITIONS ANNOUNCES RECORD-BREAKING YEAR FOR TRAVELER-SUPPORTED GLOBAL IMPACT

2026-04-20

VENTE-UNIQUE.COM : Disclosure of trading in own shares

2026-04-20

GROUPE PLASTIVALOIRE : Disclosure of trading in own shares

2026-04-20

HYDROGEN REFUELING SOLUTIONS (HRS) : HRS ANNOUNCES ITS PARTICIPATION IN THE MOUNTAIN PLANET EXHIBITION IN GRENOBLE FROM 21 TO 23 APRIL 2026

2026-04-20

William Blair Initiates Cameco at Outperform With $165 Fair Value: Is Uranium Entering a Supercycle?

2026-04-20

Steven Madden faces weak Q1, but guidance could blunt share pressure—Citi Research

2026-04-20

Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on

  • «
  • ‹
  • …
  • 2033
  • 2034
  • 2035
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies